Emerald Mutual Fund Advisers Trust’s ChemoCentryx, Inc. CCXI Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-288,980	Closed	-$14.8M	–	243
2021 Q1	$14.8M	Sell	288,980 -119,848	-29%	-$7.21M	0.49%	86
2020 Q4	$25.3M	Buy	408,828 +44,171	+12%	+$2.53M	0.88%	41
2020 Q3	$20M	Sell	364,657 -12	-0%	-$646	0.89%	43
2020 Q2	$21M	Buy	364,669 +41,989	+13%	+$2.29M	0.99%	34
2020 Q1	$13M	Buy	322,680 +158,754	+97%	+$6.74M	0.81%	46
2019 Q4	$6.48M	Buy	+163,926	New	+$2.88M	0.26%	120

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's CCXI Position: Q2 2021 in Review

Emerald Mutual Fund Advisers Trust sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 288,980 shares — an estimated $14.8M sold.

Emerald Mutual Fund Advisers Trust first reported a position in CCXI in Q4 2019 and held it in 6 quarters. The position peaked at $25.3M in Q4 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

Emerald Mutual Fund Advisers Trust reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 288,980 ChemoCentryx, Inc. shares in Q2 2021, an estimated $14.8M.
Emerald Mutual Fund Advisers Trust first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 6 quarters.
Emerald Mutual Fund Advisers Trust's ChemoCentryx, Inc. position peaked at $25.3M in Q4 2020.
146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2021, filed 29 Jul 2021.